|

Gallium 68 Dotatate Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Gallium-68 DOTA-DPhe1, Tyr3-octreotate

Pipeline

Phase 1: 1

Top Sponsors

  • Stanford University1

Indications

  • Gastroenteropancreatic Neuroendocrine Tumor1
  • Cancer1

Stanford, California1 trial

Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery

Stanford Cancer Institute Palo Alto

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.